ストックスクリーナーアプリを入手
14.35
2.94%
0.41
アフターアワーズ：
14.36
0.010
+0.07%
前日終値:
$13.94
開ける：
$13.95
24時間の取引高:
173.41K
Relative Volume:
0.63
時価総額：
$265.40M
収益：
$62.81M
当期純損益:
$-13.75M
株価収益率:
-17.94
EPS:
-0.8
ネットキャッシュフロー:
$153.00K
1週間 パフォーマンス:
+10.64%
1か月 パフォーマンス:
+8.71%
6か月 パフォーマンス:
+164.27%
1年 パフォーマンス:
+34.11%
1日の値動き範囲:
$13.71
$14.63
1週間の範囲:
$12.71
$14.63
52週間の値動き範囲:
$3.78
$15.71
Optimizerx Corp Stock (OPRX) Company Profile
OPRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
14.35 | 257.82M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
290.41 | 47.59B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
64.49 | 10.97B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
60.77 | 11.37B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
96.04 | 8.16B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.83 | 6.40B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-08 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | 開始されました | Stephens | Equal-Weight |
| 2024-07-25 | 再開されました | B. Riley Securities | Buy |
| 2024-04-04 | 開始されました | JMP Securities | Mkt Outperform |
| 2024-01-03 | 開始されました | Barclays | Equal Weight |
| 2023-02-02 | 再開されました | B. Riley Securities | Buy |
| 2022-11-01 | 開始されました | Stifel | Buy |
| 2022-07-15 | 開始されました | SVB Leerink | Outperform |
| 2021-10-18 | 再開されました | B. Riley Securities | Buy |
| 2021-04-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2019-01-03 | 開始されました | William Blair | Outperform |
すべてを表示
Optimizerx Corp (OPRX) 最新ニュース
Is OptimizeRx Corporation stock overvalued or undervaluedInvest smarter with expert stock recommendations - jammulinksnews.com
What catalysts could drive OptimizeRx Corporation stock higher in 2025Discover high-growth stocks for your portfolio - jammulinksnews.com
How many analysts rate OptimizeRx Corporation as a “Buy”Achieve exceptional returns with expert guidance - jammulinksnews.com
OptimizeRx Corporation Earnings Report Breakdown: What Investors Should KnowFree Premium Stock Market Reports - Newser
Is OptimizeRx Corporation Stock a Good Fit for Conservative InvestorsFast Gains With Reduced Risk - Newser
OptimizeRx Corp. (NASDAQ:OPRX) Shares Sold by Royce & Associates LP - MarketBeat
OptimizeRx Corp. (NASDAQ:OPRX) Receives $10.81 Average Price Target from Brokerages - MarketBeat
OPRX Delivers Solid Q1 Earnings: But Can It Sustain the Momentum? - The Globe and Mail
Optimizerx 15min Chart Sees KDJ Golden Cross, Bullish Marubozu Signal. - AInvest
Analysts Set OptimizeRx Corp. (NASDAQ:OPRX) Price Target at $10.81 - Defense World
What analysts say about OptimizeRx Corporation stockExplosive market performance - PrintWeekIndia
Is OptimizeRx Corporation a good long term investmentFree Capital Allocation Plans - jammulinksnews.com
How OptimizeRx Corporation stock performs during market volatilityStrong Buy Recommendations - Newser
Best Growth Stocks to Buy for July 22nd - TradingView
OptimizeRx Corporation Stock Analysis and ForecastFree High-Return Strategy Alerts - jammulinksnews.com
What makes OptimizeRx Corporation stock price move sharplyProven High Yield Signals - Newser
OPRX vs. GDRX: Which Health Tech Stock Has Stronger Revenue Momentum? - MSN
OptimizeRx: Stock Could Rise As Profitability Is Achieved - Seeking Alpha
Can OPRX's Patient Engagement Tools Win Amid Fierce Competition? - The Globe and Mail
OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET - The Globe and Mail
OptimizeRx Corp. to Host Conference Call for Q2 2025 Financial Results on August 7, 2025 - Quiver Quantitative
Capstone Lands Major Clean Energy Win: 90% Government-Funded Microturbine Project Shows Long-Term Success - Stock Titan
OPRX Vs. GDRX: Which Health Tech Stock Has Stronger Revenue Momentum? - Barchart.com
Why OptimizeRx Corporation stock attracts strong analyst attentionFree Risk Assessment Services - Newser
Calamos Advisors LLC Invests $289,000 in OptimizeRx Corp. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Bets on AI and Workflow Integration: Will This Pay Off? - sharewise.com
Best Growth Stocks To Buy For July 9th - Barchart.com
Best Growth Stocks to Buy for July 9th - The Globe and Mail
Can OptimizeRx Maintain Profit Growth Amid Evolving Pharma Spend? - Zacks Investment Research
OPRX Shares Rise 69.3% in 3 Months: Time to Bet on the Stock? - sharewise.com
Janney Montgomery Scott LLC Purchases 39,969 Shares of OptimizeRx Corp. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Corp. (NASDAQ:OPRX) Position Boosted by Janney Montgomery Scott LLC - Defense World
3,845 Shares in OptimizeRx Corp. (NASDAQ:OPRX) Bought by GAMMA Investing LLC - Defense World
Best Growth Stocks to Buy for June 25th - Yahoo Home
OptimizeRx appoints CEO Steve Silvestro to board of directors - Investing.com India
OptimizeRx appoints CEO Steve Silvestro to board of directors By Investing.com - Investing.com Nigeria
OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors - The Globe and Mail
Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions - Business Wire
Calculating The Fair Value Of OptimizeRx Corporation (NASDAQ:OPRX) - Yahoo Finance
OptimizeRx Co. (NASDAQ:OPRX) Shares Bought by Bank of America Corp DE - MarketBeat
OptimizeRx Co. (NASDAQ:OPRX) Shares Purchased by Bank of America Corp DE - Defense World
OptimizeRx (NASDAQ:OPRX) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says - MarketBeat
Optimizerx Corp (OPRX) 財務データ
収益
当期純利益
現金流量
EPS
Optimizerx Corp (OPRX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Silvestro Stephen L | Chief Commercial Officer |
Mar 01 '25 |
Option Exercise |
0.00 |
1,928 |
0 |
121,886 |
| Odence-Ford Marion | Chief Legal Officer & CHRO |
Mar 01 '25 |
Option Exercise |
0.00 |
771 |
0 |
70,544 |
| KLEMA CATHY | Director |
Feb 02 '25 |
Option Exercise |
0.00 |
5,109 |
0 |
11,752 |
| Odence-Ford Marion | General Counsel and CCO |
Dec 19 '24 |
Option Exercise |
0.00 |
3,927 |
0 |
28,383 |
| Silvestro Stephen L | Chief Commercial Officer |
Dec 19 '24 |
Option Exercise |
0.00 |
6,546 |
0 |
83,424 |
| Besch Doug | Chief Product Officer |
Dec 19 '24 |
Option Exercise |
0.00 |
1,964 |
0 |
12,160 |
| Stelmakh Edward | CFO/COO |
Dec 19 '24 |
Option Exercise |
0.00 |
5,237 |
0 |
38,603 |
| FEBBO WILLIAM J | CEO |
Dec 12 '24 |
Buy |
5.01 |
20,000 |
100,220 |
601,253 |
| Odence-Ford Marion | General Counsel and CCO |
Nov 08 '24 |
Option Exercise |
0.00 |
1,785 |
0 |
24,980 |
| Stelmakh Edward | CFO/COO |
Oct 11 '24 |
Option Exercise |
0.00 |
8,222 |
0 |
35,432 |
0.21%
1.00%
大文字化:
|
ボリューム (24 時間):